tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sophia Genetics sees 2023 revenue growth at or above 30%, consensus $62.12M

The company is reaffirming its previously provided guidance of: full-year reported revenue growth expected to be at or above 30%; full-year constant currency revenue growth excluding COVID-19-related revenue expected to be between 30% and 35%; and 2023 operating losses expected to be below 2022 levels.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on SOPH:

Disclaimer & DisclosureReport an Issue

1